Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-23-008451
Filing Date
2023-02-10
Accepted
2023-02-10 16:55:20
Documents
1
Period of Report
2023-02-08

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 3955
  Complete submission text file 0001209191-23-008451.txt   5326
Mailing Address 640 LEE ROAD SUITE 200 WAYNE PA 19087
Business Address 640 LEE ROAD SUITE 200 WAYNE PA 19087 484-324-7933
Aclaris Therapeutics, Inc. (Issuer) CIK: 0001557746 (see all company filings)

EIN.: 460571712 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O ACLARIS THERAPEUTICS, INC. 640 LEE ROAD, SUITE 200 WAYNE PA 19087
Business Address
Loerop James (Reporting) CIK: 0001781549 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-37581 | Film No.: 23613037